JP2006514681A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514681A5
JP2006514681A5 JP2004572190A JP2004572190A JP2006514681A5 JP 2006514681 A5 JP2006514681 A5 JP 2006514681A5 JP 2004572190 A JP2004572190 A JP 2004572190A JP 2004572190 A JP2004572190 A JP 2004572190A JP 2006514681 A5 JP2006514681 A5 JP 2006514681A5
Authority
JP
Japan
Prior art keywords
epothilone
pharmaceutical composition
concentration
intravenous infusion
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004572190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514681A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017921 external-priority patent/WO2004103267A2/en
Publication of JP2006514681A publication Critical patent/JP2006514681A/ja
Publication of JP2006514681A5 publication Critical patent/JP2006514681A5/ja
Pending legal-status Critical Current

Links

JP2004572190A 2002-05-20 2003-05-20 エポチロンdの投与方法 Pending JP2006514681A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38216602P 2002-05-20 2002-05-20
PCT/US2003/017921 WO2004103267A2 (en) 2002-05-20 2003-05-20 Methods to administer epothilone d

Publications (2)

Publication Number Publication Date
JP2006514681A JP2006514681A (ja) 2006-05-11
JP2006514681A5 true JP2006514681A5 (US20070167479A1-20070719-C00034.png) 2006-07-13

Family

ID=33476529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004572190A Pending JP2006514681A (ja) 2002-05-20 2003-05-20 エポチロンdの投与方法

Country Status (7)

Country Link
US (1) US20040072882A1 (US20070167479A1-20070719-C00034.png)
EP (1) EP1575556A2 (US20070167479A1-20070719-C00034.png)
JP (1) JP2006514681A (US20070167479A1-20070719-C00034.png)
KR (1) KR20050043796A (US20070167479A1-20070719-C00034.png)
CN (1) CN101389334A (US20070167479A1-20070719-C00034.png)
AU (1) AU2003296878A1 (US20070167479A1-20070719-C00034.png)
WO (1) WO2004103267A2 (US20070167479A1-20070719-C00034.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US8618085B2 (en) * 2000-04-28 2013-12-31 Koasn Biosciences Incorporated Therapeutic formulations of desoxyepothilones
WO2004018478A2 (en) * 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US20060235059A1 (en) * 2003-09-02 2006-10-19 Dilea Clifford Cancer treatment with epothilones
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
JP2008536479A (ja) 2005-02-11 2008-09-11 ユニバーシティ オブ サザン カリフォルニア ジスルフィド架橋を有するタンパク質の発現法
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
US9175390B2 (en) * 2008-04-25 2015-11-03 Asm International N.V. Synthesis and use of precursors for ALD of tellurium and selenium thin films
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
KR101829380B1 (ko) 2009-10-26 2018-02-19 에이에스엠 인터내셔널 엔.브이. 5a족 원소 함유 박막의 원자 층 증착용 전구체의 합성 및 용도
AU2011255647A1 (en) 2010-05-18 2012-11-15 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100561788B1 (ko) * 1996-03-12 2006-09-20 피지-티엑스엘 컴파니,엘.피. 수용성파클리탁셀전구약물을포함하는조성물및이러한조성물을포함하는이식가능한의료장치
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
CA2311929A1 (en) * 1997-12-04 1999-06-10 Bristol-Myers Squibb Company A process for the reduction of oxiranyl epothilones to olefinic epothilones
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6302838B1 (en) * 1998-02-25 2001-10-16 Novartis Ag Cancer treatment with epothilones
KR100716272B1 (ko) * 1998-11-20 2007-05-09 코산 바이오사이언시즈, 인코포레이티드 에포틸론 및 에포틸론 유도체의 생산을 위한 재조합 방법 및 물질
ATE342054T1 (de) * 1999-04-14 2006-11-15 Dana Farber Cancer Inst Inc Verfahren und zusammansetzung zur behandlung von krebs
WO2001064650A2 (en) * 2000-03-01 2001-09-07 Sloan-Kettering Institute For Cancer Research Center Synthesis of epothilones, intermediates thereto and analogues thereof
EP1320611B1 (en) * 2000-04-28 2005-11-09 Kosan Biosciences, Inc. Heterologous production of polyketides
WO2002008440A2 (en) * 2000-07-25 2002-01-31 Kosan Biosciences, Inc. Fermentation process for epothilones

Similar Documents

Publication Publication Date Title
JP2006514681A5 (US20070167479A1-20070719-C00034.png)
JP2007515469A5 (US20070167479A1-20070719-C00034.png)
JP2006523216A5 (US20070167479A1-20070719-C00034.png)
JP2012067116A5 (US20070167479A1-20070719-C00034.png)
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
JP2002532392A5 (US20070167479A1-20070719-C00034.png)
JP2008514577A5 (US20070167479A1-20070719-C00034.png)
JP2009545601A5 (US20070167479A1-20070719-C00034.png)
JP2009539769A5 (US20070167479A1-20070719-C00034.png)
JP2007514749A5 (US20070167479A1-20070719-C00034.png)
JP2012521435A5 (US20070167479A1-20070719-C00034.png)
JP2009545600A5 (US20070167479A1-20070719-C00034.png)
JP2006513184A5 (US20070167479A1-20070719-C00034.png)
JP2008517991A5 (US20070167479A1-20070719-C00034.png)
JP2010523696A (ja) 脳腫瘍を治療する方法
JP2002544231A5 (US20070167479A1-20070719-C00034.png)
CA2563058A1 (en) Supportive treatment of liver disease
JP2013541583A5 (US20070167479A1-20070719-C00034.png)
WO2007056263A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
TWI441639B (zh) 用於治療卵巢癌之包含紫杉醇之組合
JP2011500589A5 (US20070167479A1-20070719-C00034.png)
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
JP2002544227A5 (US20070167479A1-20070719-C00034.png)
JP2003514025A5 (US20070167479A1-20070719-C00034.png)
JP2002530353A5 (US20070167479A1-20070719-C00034.png)